These findings uncover the role of TULP3 in adipocyte differentiation and suggest that targeting TULP3 may offer a promising strategy for treating obesity and related metabolic disorders. This evidence concerns the gene TULP3 and obesity due to melanocortin 4 receptor deficiency.